awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26740978-7D975317-7122-4522-8C0A-40976F248991
Q26740978-7D975317-7122-4522-8C0A-40976F248991
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26740978-7D975317-7122-4522-8C0A-40976F248991
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexant
P2860
Q26740978-7D975317-7122-4522-8C0A-40976F248991
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26740978-7D975317-7122-4522-8C0A-40976F248991
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
405ac95688edc46c86b8e272b32ac9bcbddc8c98
P2860
Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.